MDM2 and nasopharyngeal carcinoma: In conclusion, we revealed the significant upregulation of circSERPINA3 expression in NPC and demonstrated its correlation with advanced clinical features, while circSERPINA3 enhanced NPC progression by targeting the miR-944/MDM2 axis.